In Practice: EOIs for Practice Owners Conference presentations Expressions of interest are now open to present at the RACGP’s annual conference for current and aspiring practice owners.
GPs to diagnose and prescribe for ADHD under ‘breakthrough’ plan West Australian GPs could soon be allowed to diagnose, initiate and manage treatment with stimulant medications.
Dire 60-day script predictions fail to materialise As well as saving patients money, more pharmacies have opened than have closed since the policy first came into effect in September 2023.
‘Life-changing’ eczema drug to stay on PBS Dupixent was at high risk of coming off the PBS as soon as this month due to high demand, but negotiations have secured its continued listing.
President and Premier hit the parkrun trail The SA Premier and Health Minister joined the RACGP President and Adelaide GPs to showcase the benefits of parkrun and encourage social prescribing.
Federal Government backs ADHD prescribing consistency In response to last year’s Senate Inquiry, it also supports-in-principle calls to review relevant MBS items and pathways to GP assessments.
Registered nurses’ prescribing powers expanded Nurses who have undergone extra training will soon be able to work to a broader scope of practice under a new prescriber arrangement.
Gabapentinoids may increase hip fractures: Study It found patients had 30% increased odds of suffering a hip fracture within two months of taking a gabapentinoid medication.
‘Sleep psychologist’ directory to assist with de-prescribing The newly launched provider registry helps GPs refer insomnia patients to CBT – in a move away from prescribing benzodiazepines.
UTI pharmacy prescribing goes nationwide The initiative can now be accessed across Australia, leading a furious RACGP President to say, ‘that’s just not good medicine’.